Oragenics (OGEN) Inventory (2010 - 2016)
Oragenics' (OGEN) quarterly Inventory came in at $241482.0 in Q1 2016, down 35.95% YoY from $377016.0 in Q2 2015, and down 24.89% on a QoQ basis from $321509.0 in Q4 2015.
Oragenics (OGEN) Inventory (2010 - 2016) Analysis & Trends
Oragenics (OGEN) has 7 years of Inventory data on file, last reported at $241482.0 in Q1 2016.
- Quarterly Inventory fell 35.95% year-over-year to $241482.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $241482.0 (down 35.95% YoY) and the FY2015 annual result came in at $321509.0, down 26.79% from the prior year.
- Inventory slipped to $241482.0 in Q1 2016, from $321509.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $439189.0 in Q4 2014 to a low of $223318.0 in Q3 2013.
- A 5-year average of $314121.6 and a median of $311425.0 in 2013 frame the typical range for Inventory.
- Annual changes were most pronounced in 2015 — Inventory surged 52.35% — and 2016, when it slumped 35.95%.
- Tracing OGEN's Inventory over 5 years: stood at $377245.0 in 2012, then dropped by 15.22% to $319846.0 in 2013, then soared by 37.31% to $439189.0 in 2014, then fell by 26.79% to $321509.0 in 2015, then retreated by 24.89% to $241482.0 in 2016.
- The last three Inventory figures came in at $241482.0 (Q1 2016), $321509.0 (Q4 2015), and $299316.0 (Q3 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 241,482.00 |
| Dec 31, 2015 | 321,509.00 |
| Sep 30, 2015 | 299,316.00 |
| Jun 30, 2015 | 364,074.00 |
| Mar 31, 2015 | 377,016.00 |
| Dec 31, 2014 | 439,189.00 |
| Sep 30, 2014 | 263,860.00 |
| Jun 30, 2014 | 238,975.00 |
| Mar 31, 2014 | 265,883.00 |
| Dec 31, 2013 | 319,846.00 |
| Sep 30, 2013 | 223,318.00 |
| Jun 30, 2013 | 303,004.00 |
| Dec 31, 2012 | 377,245.00 |
| Mar 31, 2012 | 362,985.00 |
| Dec 31, 2011 | 475,592.00 |
| Sep 30, 2011 | 465,474.00 |
| Jun 30, 2011 | 500,564.00 |
| Dec 31, 2010 | 266,628.00 |